Search the PBPK Model Repository

Quickly find freely available drug and population models in our PBPK model repository.

The models provided have been collated from published examples which authors have shared in our Published Model Collection or developed as part of various global health projects in our Global Health Collection. This search facility searches both model collections simultaneously.

To contribute published user compound and/or population files, upload your files here: Upload Model Files

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

|<

<

1

2

3

>

>|

Found 9 Matches

Brand Name(s) include: Qualaquin

Disease: Malaria

Drug Class: Antimalarials

Date Updated: 2021

The model at-a-glance

  Absorption Model

First-Order

  Volume of Distribution

Minimal PBPK (Method 1)

  Route of Elimination

CYP3A4 (fm = 0.50); renal clearance (fe = 0.1)

  Perpetrator DDI

  • CYP2D6 Inhibitor

  Validation

  • Three clinical studies describing Quinine PK were identified for model verification.
  • Three clinical DDI studies where quinine was the victim of CYP-mediated DDIs were used to verify the PBPK model.  All studies were well recovered with simulated Cmax and AUC GMRs within 1.5-fold of the observed

  Limitations

  • The Simcyp quinine PBPK model was able to recover interactions CYP3A inducers and inhibitors with reasonable accuracy.
  • Verification needed for perpetrator DDI assessment as literature data is unavailable at this time.

  Updates in V19

  • Updated in vitro­ data
    • fup: 0.199 -> 0.37
    • Caco-2 A -> B Permeability: 70 x 10-6 cm/s -> 39 x 10-6 cm/s
    • Propranolol reference Permeability: 101 x 10-6 cm/s -> 45 x 10-6 cm/s
  • Minimal PBPK with Vss predicted through Method 1
    • Updated retrograde clearance

 

|<

<

1

2

3

>

>|